DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 108 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,571,453 | +0.5% | 2,491,561 | -2.2% | 26.81% | +24.4% |
| Q2 2023 | $30,427,932 | -10.7% | 2,548,403 | 0.0% | 21.55% | -12.1% |
| Q1 2023 | $34,072,148 | -37.9% | 2,548,403 | 0.0% | 24.51% | -43.1% |
| Q4 2022 | $54,841,633 | -60.7% | 2,548,403 | -63.4% | 43.06% | -23.5% |
| Q3 2022 | $139,495,000 | -19.4% | 6,964,301 | -27.9% | 56.26% | -8.7% |
| Q2 2022 | $172,979,000 | +80.4% | 9,663,645 | 0.0% | 61.60% | +54.3% |
| Q1 2022 | $95,863,000 | -41.1% | 9,663,645 | 0.0% | 39.92% | -4.8% |
| Q4 2021 | $162,832,000 | – | 9,663,645 | – | 41.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |